Sequent Scientific (NSE:SEQUENT) Total Liabilities : ₹8,202 Mil (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Sequent Scientific Total Liabilities?

Sequent Scientific's Total Liabilities for the quarter that ended in Sep. 2024 was ₹8,202 Mil.

Sequent Scientific's quarterly Total Liabilities declined from Mar. 2024 (₹8,274.25 Mil) to Jun. 2024 (₹0.00 Mil) but then increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹8,201.80 Mil).

Sequent Scientific's annual Total Liabilities increased from Mar. 2022 (₹7,108.67 Mil) to Mar. 2023 (₹7,799.33 Mil) and increased from Mar. 2023 (₹7,799.33 Mil) to Mar. 2024 (₹8,274.25 Mil).

Sequent Scientific Total Liabilities Historical Data

The historical data trend for Sequent Scientific's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequent Scientific Total Liabilities Chart

Sequent Scientific Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

7,308.05

6,162.43

7,108.67

7,799.33

8,274.25

Sequent Scientific Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															8,182.92	-	8,274.25	-	8,201.80

Sequent Scientific Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sequent Scientific's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6269.9	+	(1718.16	+	286.19
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	8,274

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	15403.84	-	7129.59
	=	8,274

Sequent Scientific's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4887.9	+	(3023.9	+	290
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	8,202

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	15620.5	-	7418.7
	=	8,202

Sequent Scientific Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sequent Scientific's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequent Scientific Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sequent Scientific Ltd (NSE:SEQUENT) » Definitions » Total Liabilities

Traded in Other Exchanges

512529:India

Address

Plot No. E7, Road No. 22, 301, 3rd Floor, Dosti Pinnacle, Wagle Industrial Estate, Thane (West), Mumbai, MH, IND, 400 604

Website

https://www.sequent.in

Sequent Scientific Ltd is a pharmaceutical company operating animal health and analytical services. It develops API products and formulations. The company's product portfolio includes products across various therapy classes such as antibiotics, anthelmintics, pain management, and nutrition. The company's geographical segment includes Europe, Asia, and Rest of the world. It generates maximum revenue from Europe.

Sequent Scientific Headlines

No Headlines